03/25/2024 4:27 PM | Alzamend Neuro (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
03/22/2024 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 3:30 PM | Alzamend Neuro (Filer)
| Form NT 10-Q | |
03/13/2024 3:30 PM | Alzamend Neuro (Filer)
| Form PRE 14A | |
03/07/2024 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 3:38 PM | Alzamend Neuro (Subject) AULT MILTON C III (Filed by)
| Form SC 13D/A | |
02/02/2024 3:30 PM | Alzamend Neuro (Issuer) AULT MILTON C III (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
02/02/2024 3:30 PM | Alzamend Neuro (Filer) Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/25/2024 4:20 PM | Alzamend Neuro (Issuer) AULT MILTON C III (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 4:21 PM | Alzamend Neuro (Subject) AULT MILTON C III (Filed by)
| Form SC 13D/A | |
01/09/2024 3:30 PM | Alzamend Neuro (Issuer) AULT MILTON C III (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 3:30 PM | Alzamend Neuro (Issuer) AULT MILTON C III (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/15/2023 3:30 PM | Alzamend Neuro (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/16/2023 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2023 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/26/2023 5:01 PM | Alzamend Neuro (Issuer) Katzoff David J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/22/2023 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 4:09 PM | Alzamend Neuro (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
09/08/2023 4:05 PM | Alzamend Neuro (Filer)
| Form 424B5 | |
09/01/2023 3:30 PM | Alzamend Neuro (Filer)
| Form DEFA14A | |
08/24/2023 3:30 PM | Alzamend Neuro (Filer)
| Form DEF 14A | |
08/16/2023 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 11:15 PM | Alzamend Neuro (Filer)
| Form EFFECT | |
06/22/2023 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/26/2023 8:30 PM | Alzamend Neuro (Issuer) AULT MILTON C III (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2023 3:30 PM | Alzamend Neuro (Issuer) Jackman Stephan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2023 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2023 3:30 PM | Alzamend Neuro (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/31/2023 3:31 PM | Alzamend Neuro (Filer)
| Form DEF 14A | |